ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1950

Self-Reported Depression and Anxiety Among US Adults Aged 18-44 Years with Arthritis, National Health Interview Survey 2014-2016

Dana Guglielmo1, Jennifer M. Hootman2, Louise Murphy2, Michael Boring3, Kristina Theis2, Charles G. Helmick2, Kamil E. Barbour2 and Patricia Katz4, 1Oak Ridge Institute for Science and Education, Oak Ridge, TN, 2Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, 3Cutting Edge Technology and Solutions, Mesa, AZ, 4University of California San Francisco, San Francisco, CA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Anxiety, Arthritis, depression and young adults

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: 4M117 ARHP Abstract: Pain, Anxiety, & Depression–ARHP I (1946–1951)

Session Type: ARHP Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Depression and anxiety are frequent comorbid conditions among adults with arthritis, and are associated with poorer quality of life, reduced adherence and efficacy of arthritis treatment, and suicidal ideation. In the general population, younger adults have a higher prevalence of depression and anxiety than older adults. We analyzed nationally-representative population-based prevalence of self-reported depression and anxiety among 21,318 young adults (aged 18-44 years) with and without arthritis.

Methods: We combined National Health Interview Survey data from 2014, 2015, and 2016. Arthritis was “yes” to: “Have you ever been told by a doctor or other health care professional that you have arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia?” We classified respondents as having self-reported depression and/or anxiety if they had high or medium frequency (daily, weekly, or monthly) of respective symptoms. Analyses accounted for the complex survey design to make estimates representative of the US civilian, non-institutionalized population. We estimated the unadjusted weighted prevalence (%) with 95% confidence intervals (CI) of depression and anxiety by arthritis and groups defined by selected characteristics.

Results: In 2014-2016, 7.7% of young adults reported arthritis and among them, 29.0% and 48.7% reported depression and anxiety, respectively. Depression prevalence was 2.4 times higher for young adults with arthritis than those without (29.0%; CI=26.0-32.2 vs. 12.3%; CI=11.7-13.0); anxiety prevalence was 1.6 times higher (48.7%; CI=45.5-52.0 vs. 29.6%; CI=28.6-30.6). Among 1,644 young adults with arthritis, depression prevalence was high among those unable to work/disabled and anxiety prevalence was high among those unable to work/disabled and those with 3+ co-occurring chronic conditions (Figure 1). Among those with arthritis and the respective conditions, 32.1% (CI=28.1-36.4) reported taking medications for anxiety and 45.0% (CI=38.7%-51.5%) reported taking medications for depression; for both, medication use was higher compared to those without arthritis (Figure 2).  

Conclusion: Self-reported depression and anxiety are common in young adults and considerably more prevalent among those with arthritis than those without. Although there is substantial awareness of depression in adults with arthritis, anxiety prevalence was higher. Health care providers can help arthritis patients by screening for these conditions, especially in younger adults, and referring them to mental health specialists for diagnosis and treatment.

 


Disclosure: D. Guglielmo, None; J. M. Hootman, None; L. Murphy, None; M. Boring, None; K. Theis, None; C. G. Helmick, None; K. E. Barbour, None; P. Katz, None.

To cite this abstract in AMA style:

Guglielmo D, Hootman JM, Murphy L, Boring M, Theis K, Helmick CG, Barbour KE, Katz P. Self-Reported Depression and Anxiety Among US Adults Aged 18-44 Years with Arthritis, National Health Interview Survey 2014-2016 [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/self-reported-depression-and-anxiety-among-us-adults-aged-18-44-years-with-arthritis-national-health-interview-survey-2014-2016/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/self-reported-depression-and-anxiety-among-us-adults-aged-18-44-years-with-arthritis-national-health-interview-survey-2014-2016/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology